圣达生物
(603079)
| 流通市值：26.72亿 | | | 总市值：26.72亿 |
| 流通股本：1.71亿 | | | 总股本：1.71亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 608,870,278.32 | 384,474,783.09 | 184,829,589.97 | 727,405,727.98 |
| 营业收入 | 608,870,278.32 | 384,474,783.09 | 184,829,589.97 | 727,405,727.98 |
| 二、营业总成本 | 577,385,792.61 | 364,482,739.87 | 177,350,467.11 | 729,017,572.14 |
| 营业成本 | 485,917,821.02 | 307,567,509.1 | 147,712,333.89 | 610,950,920.09 |
| 税金及附加 | 7,426,983.96 | 4,780,786.68 | 2,246,979.86 | 9,412,757.49 |
| 销售费用 | 10,092,998.05 | 6,484,170.01 | 2,769,640.39 | 14,202,679.43 |
| 管理费用 | 49,669,221.61 | 32,220,985.38 | 17,751,626.7 | 61,963,343.52 |
| 研发费用 | 29,025,818.97 | 18,806,646.7 | 7,896,868.68 | 42,924,788.08 |
| 财务费用 | -4,747,051 | -5,377,358 | -1,026,982.41 | -10,436,916.47 |
| 其中:利息费用 | 1,099,956.42 | 848,173.63 | 573,615.97 | 1,537,370.09 |
| 其中:利息收入 | 4,109,259.65 | 3,179,259 | 1,272,144.08 | 8,406,832.62 |
| 加:公允价值变动收益 | 2,068.04 | 1,109.68 | - | 100.88 |
| 加:投资收益 | 3,015,295.08 | 2,929,906.19 | 1,691,249.12 | 406,508 |
| 资产处置收益 | - | - | - | 202,167.26 |
| 资产减值损失(新) | -5,972,851.85 | -5,911,600.85 | -2,710,357.73 | -50,809,509.26 |
| 信用减值损失(新) | -6,655,326.71 | -4,295,392.98 | -856,530.56 | -3,160,793.13 |
| 其他收益 | 6,350,545.46 | 4,635,410.46 | 1,902,018.6 | 9,297,391.11 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 28,224,215.73 | 17,351,475.72 | 7,505,502.29 | -45,675,979.3 |
| 加:营业外收入 | 11,170,564.99 | 11,016,563.16 | 65,902.38 | 2,990,530.65 |
| 减:营业外支出 | 4,187,764.43 | 4,175,051.24 | 2,659.37 | 2,622,277.72 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 35,207,016.29 | 24,192,987.64 | 7,568,745.3 | -45,307,726.37 |
| 减:所得税费用 | 7,797,813.78 | 4,714,752.03 | 2,264,864.28 | 8,893,963.77 |
| 六、净利润 | 27,409,202.51 | 19,478,235.61 | 5,303,881.02 | -54,201,690.14 |
| 持续经营净利润 | 27,409,202.51 | 19,478,235.61 | 5,303,881.02 | -54,201,690.14 |
| 归属于母公司股东的净利润 | 21,679,027.87 | 16,494,835.49 | 3,813,060.72 | -54,062,928.21 |
| 少数股东损益 | 5,730,174.64 | 2,983,400.12 | 1,490,820.3 | -138,761.93 |
| (一)基本每股收益 | 0.13 | 0.1 | 0.02 | -0.32 |
| (二)稀释每股收益 | 0.13 | 0.1 | 0.02 | -0.32 |
| 九、综合收益总额 | 27,409,202.51 | 19,478,235.61 | 5,303,881.02 | -54,201,690.14 |
| 归属于母公司股东的综合收益总额 | 21,679,027.87 | 16,494,835.49 | 3,813,060.72 | -54,062,928.21 |
| 归属于少数股东的综合收益总额 | 5,730,174.64 | 2,983,400.12 | 1,490,820.3 | -138,761.93 |
| 公告日期 | 2024-10-26 | 2024-08-23 | 2024-04-20 | 2024-04-20 |
| 审计意见(境内) | | | | 标准无保留意见 |